rkdewan

 A recent decision by the Hon’ble Delhi High Court in Cellectis v. Assistant Controller of  Patents  showcases the delicate balance between judicial scrutiny and patent law, especially in the complex realm of gene-based immunotherapies. The Court’s allowance of amendments to patent claims reflects its willingness to accommodate genuine efforts at clarifying inventive scope— particularly when procedural objections risk overshadowing scientific advancement. At the heart of the matter lies Cellectis’s patent application titled “Method for Engineering Allogenic and Highly Active T-Cells for Immunotherapy.” The invention proposes an ex vivo method for modifying human T-cells using gene editing tools to inactivate both T-cell receptor (TCR) components and immune checkpoint proteins, followed by the introduction of chimeric antigen receptors (CARs) to create universal, highly active, non-alloreactive donorderived T-cells. These modified T-cells promise scalable, off-theshel...

 “History is not the past but a map of the past, drawn from a particular point of view, to be useful to the modern traveller.” very well said by US historian Henry Glassie and true with respect to various Intellectual Property Rights systems in the world including India, which has a robust patent system very much incompliance with International standards and agreements. Patent A patent is an outcome of curiosity and is based on the ideas reduced in the practice. It is the most important form of Intellectual Property Right (IPR) for an invention, awarded territorially by the Government of India to the creator of the invention the sole right to make, use, sell, offer to sell and or import that invention for a set period. Hence, the patent is an exclusive statutory right rather negative right granted by a government to an inventor for a limited period in exchange for the complete disclosure of their invention. What is the Patent System in India A branch of Intellectua...